Literature DB >> 12595518

Prevention and treatment of acute renal failure in sepsis.

An S De Vriese1.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12595518     DOI： 10.1097/01.asn.0000055652.37763.f7

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  10 in total

1.  The association of receptor of advanced glycated end products and inflammatory mediators contributes to endothelial dysfunction in a prospective study of acute kidney injury patients with sepsis.

Authors:  Nermin A H Sadik; Waleed A Mohamed; Mohamed I Ahmed
Journal:  Mol Cell Biochem       Date:  2011-08-03       Impact factor: 3.396

2.  A novel conditional platelet depletion mouse model reveals the importance of platelets in protection against Staphylococcus aureus bacteremia.

Authors:  L M Wuescher; A Takashima; R G Worth
Journal:  J Thromb Haemost       Date:  2014-12-30       Impact factor: 5.824

3.  Correlation between thrombopoietin and inflammatory factors, platelet indices, and thrombosis in patients with sepsis: A retrospective study.

Authors:  Wan-Hua Xu; Li-Chan Mo; Mao-Hua Shi; Hui Rao; Xiao-Yong Zhan; Mo Yang
Journal:  World J Clin Cases       Date:  2022-05-06       Impact factor: 1.534

Review 4.  Leukocyte recruitment and acute renal failure.

Authors:  Kai Singbartl; Klaus Ley
Journal:  J Mol Med (Berl)       Date:  2003-12-10       Impact factor: 4.599

Review 5.  Selective iNOS inhibition for the treatment of sepsis-induced acute kidney injury.

Authors:  Suzanne Heemskerk; Rosalinde Masereeuw; Frans G M Russel; Peter Pickkers
Journal:  Nat Rev Nephrol       Date:  2009-09-29       Impact factor: 28.314

6.  Effects of ghrelin on sepsis-induced acute kidney injury: one step forward.

Authors:  Akef Khowailed; Sandra Mourad Younan; Hend Ashour; Abd Elkarim Kamel; Nivin Sharawy
Journal:  Clin Exp Nephrol       Date:  2014-07-08       Impact factor: 2.801

7.  Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effects.

Authors:  H Yasuda; P S T Yuen; X Hu; H Zhou; R A Star
Journal:  Kidney Int       Date:  2006-05       Impact factor: 10.612

8.  Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial.

Authors:  Peter Pickkers; Suzanne Heemskerk; Jeroen Schouten; Pierre-François Laterre; Jean-Louis Vincent; Albertus Beishuizen; Philippe G Jorens; Herbert Spapen; Michael Bulitta; Wilbert H M Peters; Johannes G van der Hoeven
Journal:  Crit Care       Date:  2012-01-23       Impact factor: 9.097

9.  Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy.

Authors:  Federica Melazzini; Marta Colaneri; Federica Fumoso; Giulia Freddi; Marco Vincenzo Lenti; Teresa Chiara Pieri; Davide Piloni; Patrizia Noris; Carla Pieresca; Paola Stefania Preti; Mariaconcetta Russo; Angelo Corsico; Guido Tavazzi; Fausto Baldanti; Antonio Triarico; Francesco Mojoli; Raffaele Bruno; Antonio Di Sabatino
Journal:  Intern Emerg Med       Date:  2020-11-08       Impact factor: 3.397

10.  Nicotinic acetylcholine receptor agonists attenuate septic acute kidney injury in mice by suppressing inflammation and proteasome activity.

Authors:  Prodyot K Chatterjee; Michael M Yeboah; Oonagh Dowling; Xiangying Xue; Saul R Powell; Yousef Al-Abed; Christine N Metz
Journal:  PLoS One       Date:  2012-05-07       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.